Sartorius AG's Investor Relations Service

Sartorius Group | Nine-Months Results 2014

Joachim Kreuzburg, CEO of the Sartorius Group, has discussed the nine-month figures for 2014 on October 21, at 3.30 p.m. CET.

Download Presentation on Nine-Month Results 2014  (1.1 MB)

Download Webcast (10.8 MB)

News

Sartorius Opens New Application Center in Shanghai

Goettingen | Shanghai, October 30, 2014 – Sartorius, a leading international laboratory and pharmaceutical equipment supplier, officially opened a new application center at its Shanghai office last...[more]

Date: 30.10.2014     Category: Sartorius, Sartorius Stedim Biotech

Nine-month Figures for 2014: Sartorius Grows in Order Intake, Sales Revenue and Earnings

Group sales revenue +9.6%; order intake +10.1%; underlying EBITDA +10.7% | Strong growth in the Bioprocess Solutions Division; positive development trends for Lab Products & Services and Industrial...[more]

Date: 21.10.2014     Category: Sartorius

Sartorius Preference Share (SRT3)

Petra Kirchhoff

Vice President of Corporate Communications & Investor Relations

petra.kirchhoff
(at)sartorius.com

Phone: +49 551 308-1686

Andreas Theisen

Director Investor Relations

andreas.theisen
(at)sartorius.com

Phone: +49 551 308-1668